Skip to main content

Peer Review reports

From: Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

Original Submission
27 Jul 2020 Submitted Original manuscript
30 Sep 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
10 Oct 2020 Editorially accepted
27 Oct 2020 Article published 10.1186/s13063-020-04796-z

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215